Big Move For RedHill Biopharma Ltd.
RedHill Biopharma Ltd. (RDHL:NASDAQ) jumped higher at $0.68, representing a gain of 46.6%. On Wed, Oct 19, 2022, RDHL:NASDAQ hit a New 2-Week High of $0.68. The stock appeared on our News Catalysts scanner on Wed, Oct 19, 2022 at 11:02 AM in the 'PRIVATE PLACEMENT' category. From Wed, Oct 05, 2022, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Wed, Oct 19, 2022 at $0.96 with a volume of 82M+.
About RedHill Biopharma Ltd. (RDHL:NASDAQ)
RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.
Top 10 Gainers:
- Amprius Technologies Inc. (AMPX:NYSE), 77.29%
- Mullen Automotive Inc. (MULN:NASDAQ), 57.12%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 51.59%
- Creatd Inc. (CRTD:NASDAQ), 47.17%
- SenesTech, Inc. (SNES:NASDAQ), 46.55%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 46.55%
- Microvast Holdings Inc. (MVST:NASDAQ), 40.25%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 34.42%
- Cabaletta Bio, Inc. (CABA:NASDAQ), 31.13%
- HV Bancorp, Inc. (HVBC:NASDAQ), 27.43%